VERTEX PHARMACEUTICALS INC / MA Insider Trading for November 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA for November 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 19 2018 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 163.75 | 12 | 1,965 | 16,087 | 16.1 K to 16.1 K (-0.07 %) |
Nov 19 2018 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 163.75 | 90 | 14,738 | 39,609 | 39.7 K to 39.6 K (-0.23 %) |
Nov 19 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 163.75 | 61 | 9,989 | 46,662 | 46.7 K to 46.7 K (-0.13 %) |
Nov 19 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 163.75 | 29 | 4,749 | 46,752 | 46.8 K to 46.8 K (-0.06 %) |
Nov 19 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 163.75 | 100 | 16,375 | 39,113 | 39.2 K to 39.1 K (-0.26 %) |
Nov 08 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 131.89 | 2,125 | 280,266 | 6,375 | |
Nov 08 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 179.00 | 2,125 | 380,375 | 46,752 | 48.9 K to 46.8 K (-4.35 %) |
Nov 08 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 131.89 | 2,125 | 280,266 | 48,877 | 46.8 K to 48.9 K (+4.55 %) |
Nov 08 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 131.89 | 2,125 | 280,266 | 6,375 | |
Nov 08 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 181.89 | 2,125 | 386,516 | 39,113 | 41.2 K to 39.1 K (-5.15 %) |
Nov 08 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 131.89 | 2,125 | 280,266 | 41,238 | 39.1 K to 41.2 K (+5.43 %) |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Option Exercise | M | 86.52 | 1,941 | 167,935 | 17,475 | |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Option Exercise | M | 91.05 | 2,155 | 196,213 | 10,777 | |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 174.41 | 428 | 74,647 | 46,662 | 47.1 K to 46.7 K (-0.91 %) |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 173.74 | 1,213 | 210,747 | 47,090 | 48.3 K to 47.1 K (-2.51 %) |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 172.70 | 300 | 51,810 | 48,303 | 48.6 K to 48.3 K (-0.62 %) |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Buy | M | 86.52 | 1,941 | 167,935 | 48,603 | 46.7 K to 48.6 K (+4.16 %) |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 176.04 | 100 | 17,604 | 46,662 | 46.8 K to 46.7 K (-0.21 %) |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 175.31 | 100 | 17,531 | 46,762 | 46.9 K to 46.8 K (-0.21 %) |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 173.35 | 100 | 17,335 | 46,862 | 47 K to 46.9 K (-0.21 %) |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 172.81 | 1,255 | 216,877 | 46,962 | 48.2 K to 47 K (-2.60 %) |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 171.93 | 600 | 103,158 | 48,217 | 48.8 K to 48.2 K (-1.23 %) |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Buy | M | 91.05 | 2,155 | 196,213 | 48,817 | 46.7 K to 48.8 K (+4.62 %) |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Option Exercise | M | 86.52 | 2,330 | 201,592 | 20,969 | |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 172.08 | 2,330 | 400,946 | 39,609 | 41.9 K to 39.6 K (-5.56 %) |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Buy | M | 86.52 | 2,330 | 201,592 | 41,939 | 39.6 K to 41.9 K (+5.88 %) |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 86.52 | 1,553 | 134,366 | 13,980 | |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 109.14 | 4,250 | 463,845 | 4,250 | |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 172.08 | 1,553 | 267,240 | 46,752 | 48.3 K to 46.8 K (-3.21 %) |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 86.52 | 1,553 | 134,366 | 48,305 | 46.8 K to 48.3 K (+3.32 %) |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 172.08 | 4,250 | 731,340 | 46,752 | 51 K to 46.8 K (-8.33 %) |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 109.14 | 4,250 | 463,845 | 51,002 | 46.8 K to 51 K (+9.09 %) |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 86.52 | 2,330 | 201,592 | 20,969 | |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | M | 91.05 | 1,796 | 163,526 | 8,980 | |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 172.08 | 2,330 | 400,946 | 39,113 | 41.4 K to 39.1 K (-5.62 %) |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 86.52 | 2,330 | 201,592 | 41,443 | 39.1 K to 41.4 K (+5.96 %) |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 175.36 | 1,796 | 314,947 | 39,113 | 40.9 K to 39.1 K (-4.39 %) |
Nov 06 2018 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Buy | M | 91.05 | 1,796 | 163,526 | 40,909 | 39.1 K to 40.9 K (+4.59 %) |
Nov 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 91.05 | 2,155 | 196,213 | 10,776 | |
Nov 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 175.36 | 2,155 | 377,901 | 46,752 | 48.9 K to 46.8 K (-4.41 %) |
Nov 05 2018 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 91.05 | 2,155 | 196,213 | 48,907 | 46.8 K to 48.9 K (+4.61 %) |